Department of General Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Clin Transplant. 2011 Mar-Apr;25(2):255-64. doi: 10.1111/j.1399-0012.2010.01241.x.
Delayed graft function (DGF) is more common in recipients of kidney transplants from donation after cardiac death (DCD) donors compared to donation after brain death (DBD) donors.
Single-center retrospective study to evaluate the impact of DGF on controlled (Maastricht category III) DCD donor kidney transplant outcomes.
From 10/01 to 6/08, 578 adult deceased donor kidney transplants were performed including 70 (12%) from DCD and 508 (88%) from DBD donors. Mean follow-up was 36 months. DCD donor kidney transplants had significantly greater rates of DGF (57% DCD vs. 21% DBD, p < 0.0001)) and acute rejection (29% DCD vs. 16% DBD, p = 0.018) compared to DBD donor kidney transplants, but patient and graft survival rates were similar. DBD donor kidney transplants with DGF (n = 109) had significantly greater rates of death-censored graft loss (12.5% DCD vs. 31% DBD), primary non-function (0 DCD vs. 10% DBD) and higher 2 year mean serum creatinine levels (1.4 DCD vs. 2.7 mg/dL DBD) compared to DCD donor kidney transplants with DGF (n = 40, all p < 0.04). On univariate analysis, the presence of acute rejection and older donor age were the only significant risk factors for death-censored graft loss in DCD donor kidney transplants, whereas DGF was not a risk factor.
Despite higher rates of DGF and acute rejection in DCD donor kidney transplants, subsequent outcomes in DCD donor kidney transplants with DGF are better than in DBD donor kidney transplants experiencing DGF, and similar to outcomes in DCD donor kidney transplants without DGF.
与脑死亡(DBD)供体相比,心脏死亡后(DCD)供体的肾脏移植更常发生延迟移植物功能(DGF)。
这是一项单中心回顾性研究,旨在评估 DGF 对受控(马斯特里赫特分类 III)DCD 供体肾脏移植结局的影响。
2010 年 10 月至 2008 年 6 月,共进行了 578 例成人尸体供肾移植,其中 70 例(12%)来自 DCD,508 例(88%)来自 DBD。平均随访 36 个月。与 DBD 供体肾移植相比,DCD 供体肾移植的 DGF(57% DCD 比 21% DBD,p < 0.0001)和急性排斥反应(29% DCD 比 16% DBD,p = 0.018)发生率明显更高,但患者和移植物存活率相似。DBD 供体肾移植发生 DGF(n = 109)的患者,在无死亡情况下发生移植物丢失(12.5% DCD 比 31% DBD)、原发性无功能(0 DCD 比 10% DBD)和更高的 2 年平均血清肌酐水平(1.4 DCD 比 2.7 mg/dL DBD)发生率明显高于 DCD 供体肾移植发生 DGF(n = 40,所有 p < 0.04)。在单变量分析中,急性排斥反应和供体年龄较大是 DCD 供体肾移植发生无死亡情况下移植物丢失的唯一显著危险因素,而 DGF 不是危险因素。
尽管 DCD 供体肾移植中 DGF 和急性排斥反应的发生率较高,但 DCD 供体肾移植发生 DGF 的后续结局优于 DBD 供体肾移植发生 DGF 的结局,与 DCD 供体肾移植无 DGF 的结局相似。